Buch, Englisch, 521 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 832 g
Sources, Fate, Effects and Risks
Buch, Englisch, 521 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 832 g
ISBN: 978-3-642-09412-5
Verlag: Springer
The study of pharmaceuticals in the environment is a relatively new area of research. This edition addresses the most important issues in the field for the near future. Following the resounding success of the first two editions, this new edition has been brought up-to-date and greatly extended. It includes the status of research on soil, paying particular attention to field studies in terrestrial and aquatic environments as well as new substance categories such as tetracylines and chinolones and the latest results concerning contamination of the environment and risk reduction. In line with the newest developments worldwide there are now many more contributions from international authors. This volume also caters for the new requirements confronting European and American researchers since publication of the first edition. This book provides the reader with a well-founded overview which even specialists will appreciate.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Naturwissenschaften Chemie Analytische Chemie
- Geowissenschaften Umweltwissenschaften Umweltmanagement, Umweltökonomie
- Technische Wissenschaften Umwelttechnik | Umwelttechnologie Wasserversorgung, Wasseraufbereitung
- Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie
- Geowissenschaften Umweltwissenschaften Umweltverschmutzung, Umweltkriminalität, Umweltrecht
- Geowissenschaften Umweltwissenschaften Umweltüberwachung, Umweltanalytik, Umweltinformatik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Naturwissenschaften Biowissenschaften Mikrobiologie
Weitere Infos & Material
General Aspects.- Pharmaceuticals in the Environment – A Brief Summary.- Special Characteristics of Pharmaceuticals Related to Environmental Fate.- Sources, Occurrence and Fate.- Drug Production Facilities – An Overlooked Discharge Source for Pharmaceuticals to the Environment.- Substance Flows Associated with Medical Care – Significance of Different Sources.- Pharmaceutical Residues in Northern European Environments: Consequences and Perspectives.- Antibiotics in the Environment.- Veterinary Antibiotics in Dust: Sources, Environmental Concentrations, and Possible Health Hazards.- Fate of Veterinary Medicines Applied to Soils.- Pharmaceuticals as Environmental Contaminants: Modeling Distribution and Fate.- Environmental Exposure Modeling: Application of PhATE™ and Great-ER to Human Pharmaceuticals in the Environment.- Exposure Assessment Methods for Veterinary and Human-Use Medicines in the Environment: PEC vs. MEC Comparisons.- Effects.- Effects of Pharmaceuticals on Aquatic Organisms.- Another Example of Effects of Pharmaceuticals on Aquatic Invertebrates: Fluoxetine and Ciprofloxacin.- Effects of Antibiotics and Virustatics in the Environment.- Realizing the Potential Benefits of Small Animal Models for the Aquatic Hazard Assessment of Human Pharmaceuticals: A Conceptual Approach.- On the Ecotoxicology of Pharmaceutical Mixtures.- Chronic Mixture Toxicity of Pharmaceuticals to Daphnia – The Example of Nonsteroidal Anti-Inflammatory Drugs.- The Ecotoxicological Effects of Pharmaceuticals (Antibiotics and Antiparasiticides) in the Terrestrial Environment – a Review.- Odorants – Potent Substances at Minor Concentrations: The Ecological Role of Infochemicals.- Risk Assessment.- European Developments in the Environmental Risk Assessment of Pharmaceuticals.-The State and the Future Development/Perspective of Environmental Risk Assessment of Medicinal Products for Human Use: Aspects of Its Regulations in Japan.- Deterministic and Probabilistic Environmental Risk Assessment for Diazepam.- Comparison of Prospective and Retrospective Environmental Risk Assessments of Human Pharmaceuticals.- Methodological Aspects Concerning the Environmental Risk Assessment for Medicinal Products; Research Challenges.- Risk Management.- Strategies for Reducing the Input of Pharmaceuticals into the Environment.- Cost Action 636 Xenobiotics in the Urban Water Cycle – A Network for Collaboration within Europe.- Removal of Pharmaceutical Residues from Contaminated Raw Water Sources by Membrane Filtration.- Photooxidation as Advanced Oxidation Treatment of Hospital Effluents.- Pharmaceuticals and Environment: Role of Community Pharmacies.- Mitigation of the Pharmaceutical Outlet into the Environment – Experiences from Sweden.- Pharmaceutical Waste.
